Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

NewAmsterdam Pharma (NAMS) Asset Utilization Ratio (2024 - 2025)

NewAmsterdam Pharma's Asset Utilization Ratio history spans 2 years, with the latest figure at 0.03 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 58.61% year-over-year to 0.03; the TTM value through Dec 2025 reached 0.03, down 58.61%, while the annual FY2025 figure was 0.03, 63.37% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.03 at NewAmsterdam Pharma, down from 0.04 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.08 in Q2 2025 and bottomed at 0.02 in Q2 2024.